Prolia 60 mg Injection

Prolia 60 mg Injection is designed for patients who need powerful, long-term bone protection. While our bodies naturally remove old bone and replace it with new bone, osteoporosis causes this balance to shift, leading to fragile skeletons. Prolia intervenes by blocking the RANKL pathway, effectively "switching off" the cells that break down bone. This allows the bone-building cells (osteoblasts) to catch up, resulting in denser, more resilient bones.

Why Prolia 60 mg is a Clinical Leader

• Proven Fracture Reduction: Clinical studies show a 68% reduction in the risk of new spine fractures and a 40% reduction in hip fracture risk.

• Convenient 6-Month Schedule: Only two doses per year are required, making it much easier to stay compliant compared to daily or weekly oral bisphosphonates.

• Effective for Cancer Patients: Prolia is the gold standard for preventing bone loss in women receiving aromatase inhibitors for breast cancer and men receiving androgen deprivation therapy for prostate cancer.

• Targeted Action: Unlike many other drugs, Prolia's effects are reversible, providing a flexible approach to long-term bone health management.

Clinical Administration & Proper Storage

1. Professional Administration: Prolia must be administered by a healthcare professional as a subcutaneous injection in the upper arm, upper thigh, or abdomen.

2. Mandatory Supplements: Most patients should take daily Calcium (1000 mg) and Vitamin D (at least 400 IU) to prevent low blood calcium levels while on Prolia.

3. Strict Cold-Chain Storage: Must be stored in a refrigerator at 2°C to 8°C (36°F to 46°F). Do not freeze.

4. Handling: Protect the pre-filled syringe from light by keeping it in the original carton. It can be brought to room temperature (up to 25°C) for 15–30 minutes before injection for comfort.